Presymptomatic Studies in ALS: Rationale, Challenges, and Approach

Overview

Journal Neurology

Specialty Neurology

Date 2012 Oct 17

PMID 23071166

Citations 56

Authors

Michael Benatar

Joanne Wuu

Affiliations

Soon will be listed here.

Citing Articles

Quantitative and Computational Spinal Imaging in Neurodegenerative Conditions and Acquired Spinal Disorders: Academic Advances and Clinical Prospects.

McKenna M, Kleinerova J, Power A, Garcia-Gallardo A, Tan E, Bede P Biology (Basel). 2024; 13(11).

PMID: 39596864 PMC: 11592215. DOI: 10.3390/biology13110909.

Body mass index is lower in asymptomatic expansion carriers but not in pathogenic variant carriers compared to gene negatives.

Lee I, Garret M, Wuu J, Harrington E, Berry J, Miller T Amyotroph Lateral Scler Frontotemporal Degener. 2024; 25(7-8):672-679.

PMID: 39192497 PMC: 11496032. DOI: 10.1080/21678421.2024.2396831.

Enhancing Clinical Infrastructure for the Delivery of Intrathecal and Genetic Therapies: A Qalsody (Tofersen) Model for Patients With -ALS.

Morganroth J, Bardakjian T, Dratch L, Quinn C, Elman L Neurol Clin Pract. 2024; 14(4):e200303.

PMID: 38855716 PMC: 11157423. DOI: 10.1212/CPJ.0000000000200303.

The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology.

Benatar M, Wuu J, Huey E, McMillan C, Petersen R, Postuma R Nat Rev Neurol. 2024; 20(6):364-376.

PMID: 38769202 PMC: 11216694. DOI: 10.1038/s41582-024-00961-z.

From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.

Toader C, Dobrin N, Brehar F, Popa C, Covache-Busuioc R, Glavan L Int J Mol Sci. 2023; 24(22).

PMID: 38003309 PMC: 10671641. DOI: 10.3390/ijms242216119.

References

Murphy M, Quinn S, Young J, Parkin P, Taylor B . Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008; 71(23):1889-95. DOI: 10.1212/01.wnl.0000336653.65605.ac. View

Aggarwal A, Nicholson G . Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation. J Neurol Neurosurg Psychiatry. 2002; 73(2):199-201. PMC: 1737965. DOI: 10.1136/jnnp.73.2.199. View

Morrish P, Rakshi J, Bailey D, Sawle G, Brooks D . Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry. 1998; 64(3):314-9. PMC: 2170010. DOI: 10.1136/jnnp.64.3.314. View

Bechtel N, Scahill R, Rosas H, Acharya T, van den Bogaard S, Jauffret C . Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 2010; 75(24):2150-60. PMC: 3013584. DOI: 10.1212/WNL.0b013e3182020123. View

Vucic S, Winhammar J, Rowe D, Kiernan M . Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers. Clin Neurophysiol. 2010; 121(10):1781-5. DOI: 10.1016/j.clinph.2010.02.164. View

Carew J, Nair G, Andersen P, Wuu J, Gronka S, Hu X . Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS. Neurology. 2011; 77(14):1370-5. PMC: 3182757. DOI: 10.1212/WNL.0b013e318231526a. View

Jack Jr C, Knopman D, Jagust W, Shaw L, Aisen P, Weiner M . Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010; 9(1):119-28. PMC: 2819840. DOI: 10.1016/S1474-4422(09)70299-6. View

Rutkove S . Electrical impedance myography: Background, current state, and future directions. Muscle Nerve. 2009; 40(6):936-46. PMC: 2824130. DOI: 10.1002/mus.21362. View

Eisen A, Weber M . The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve. 2001; 24(4):564-73. DOI: 10.1002/mus.1042. View

10.

Van Deerlin V, Leverenz J, Bekris L, Bird T, Yuan W, Elman L . TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008; 7(5):409-16. PMC: 3546119. DOI: 10.1016/S1474-4422(08)70071-1. View

11.

Renton A, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs J . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72(2):257-68. PMC: 3200438. DOI: 10.1016/j.neuron.2011.09.010. View

12.

Deng H, Chen W, Hong S, Boycott K, Gorrie G, Siddique N . Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011; 477(7363):211-5. PMC: 3169705. DOI: 10.1038/nature10353. View

13.

Chou S, Norris F . Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve. 1993; 16(8):864-9. DOI: 10.1002/mus.880160810. View

14.

Vance C, Rogelj B, Hortobagyi T, De Vos K, Nishimura A, Sreedharan J . Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009; 323(5918):1208-1211. PMC: 4516382. DOI: 10.1126/science.1165942. View

15.

Benatar M, Polak M, Kaplan S, Glass J . Preventing familial amyotrophic lateral sclerosis: is a clinical trial feasible?. J Neurol Sci. 2006; 251(1-2):3-9. DOI: 10.1016/j.jns.2006.05.069. View

16.

Ravits J, Paul P, Jorg C . Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007; 68(19):1571-5. DOI: 10.1212/01.wnl.0000260965.20021.47. View

17.

Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K . Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2010; 82(6):623-7. DOI: 10.1136/jnnp.2010.224501. View

18.

Vucic S, Nicholson G, Kiernan M . Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008; 131(Pt 6):1540-50. DOI: 10.1093/brain/awn071. View

19.

Fanos J, Gelinas D, Miller R . "You have shown me my end": attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis. Am J Med Genet A. 2004; 129A(3):248-53. DOI: 10.1002/ajmg.a.30178. View

20.

Ravits J, La Spada A . ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009; 73(10):805-11. PMC: 2739608. DOI: 10.1212/WNL.0b013e3181b6bbbd. View